Insulet (PODD) Tops Q3 EPS by 4c; Boosts FY16 Revenue Outlook
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $150.58 +1.65%
Revenue Growth %: +18.1%
Financial Fact:
Sales and marketing: 22.15M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +18.1%
Financial Fact:
Sales and marketing: 22.15M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q3 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $94.9 million versus the consensus estimate of $89.75 million.
GUIDANCE:
Insulet sees FY2016 revenue of $362-365 million, versus prior guidance of $345-355 million and the consensus of $351.5 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- Smith & Wesson Brands (SWBI) Tops Q1 EPS by 13c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
